Elan rallies as J&J to invest $1 billion-plus
Johnson & Johnson plans to make a $1 billion investment in Irish drugmaker Elan . in exchange for commercial rights to its experimental Alzheimer’s disease medications, and will further fund development efforts in this area up to $500 million.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here